Dash Bio
Dash Bio provides automated bioanalysis for preclinical and clinical drug testing.
$30MSeries A
Role not disclosedSV
Swift Ventures
Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $30M 1 disclosed · full round size, not this investor’s share